RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:2848

Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome

medium confidenceDisorder

Also known as: Arthropathy-camptodactyly syndrome · CACP syndrome · Pericarditis-arthropathy-camptodactyly syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

293

78.5th percentile

Trials

0

Interventional, condition-specific

Researchers

1,168

Distinct authors in sample

Gene link

PRG4

Definitive

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

A rare, genetic, rheumatologic disease characterized by or early-onset camptodactyly and symmetrical, polyarticular, non-inflammatory, large joint arthropathy with synovial hyperplasia, as well as coxa vara deformity and, occasionally, non-inflammatory pericarditis.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (7)

CACP · Jacobs syndrome · PAC syndrome · arthropathy-camptodactyly syndrome · camptodactyly-arthropathy-coxa vara-pericarditis syndrome · camptodactyly-arthropathy-pericarditis syndrome · pericarditis-arthropathy-camptodactyly syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Definitive — PRG4

  2. LiteraturePresent

    293 matched papers (198 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (PRG4).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

293

293 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

293 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

198 in the last 10 years · medium confidence · 78.5th percentile (publications denominator)

Phrase hits: 293 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,168

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Jay GD15 papers · 2025

    Department of Emergency Medicine, Warren Alpert School of Medicine and Rhode Island Hospital, Providence, RI 02903, USA. gjay@lifespan.org.

    Papers in Europe PMC
  2. 02
    Warman ML10 papers · 2015

    Howard Hughes Medical Institute and Department of Genetics, Case Western Reserve University, School of Medicine, Cleveland, OH, United States of America; Howard Hughes Medical Institute and Orthopaedics Research Laboratories, Boston Children's Hospital, and Departments of Genetics and Orthopaedic Surgery, Harvard Medical School, Boston, MA, United States of America.

    Papers in Europe PMC
  3. 03
    Reddi AH6 papers · 2017

    Center for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, California, USA ahreddi@ucdavis.edu.

    Papers in Europe PMC
  4. 04
    Zhang LX6 papers · 2024

    Department of Emergency Medicine, Warren Alpert School of Medicine and Rhode Island Hospital, Providence, RI 02903, USA. lzhang1@lifespan.org.

    Papers in Europe PMC
  5. 05
    Schmidt TA5 papers · 2025

    Biomedical Engineering Department, School of Dental Medicine, University of Connecticut, Farmington, CT, USA.

    Papers in Europe PMC
  6. 06
    Athanasiou KA4 papers · 2020

    Lawrence Ellison Center for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, United States; Department of Biomedical Engineering, University of California, Davis, CA, United States.

    Papers in Europe PMC
  7. 07
    Elsaid KA4 papers · 2024

    Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, 92618, USA. elsaid@chapman.edu.

    Papers in Europe PMC
  8. 08
    McNary SM4 papers · 2015

    1 Department of Orthopaedic Surgery, Lawrence Ellison Center for Tissue Regeneration and Repair, School of Medicine, University of California , Davis, Sacramento, California.

    Papers in Europe PMC
  9. 09
    Ajumobi T3 papers · 2026

    School of Medicine, The Johns Hopkins University, Baltimore, MD, USA.

    Papers in Europe PMC
  10. 10
    Al-Mayouf SM3 papers · 2018

    Pediatric Rheumatology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

medium confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome" OR "Arthropathy-camptodactyly syndrome" OR "CACP syndrome" OR "Pericarditis-arthropathy-camptodactyly syndrome" OR "Jacobs syndrome" OR "PAC syndrome" OR "camptodactyly-arthropathy-coxa vara-pericarditis syndrome" OR "camptodactyly-arthropathy-pericarditis syndrome"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome" OR "Arthropathy-camptodactyly syndrome" OR "CACP syndrome" OR "Pericarditis-arthropathy-camptodactyly syndrome" OR "Jacobs syndrome" OR "PAC syndrome" OR "camptodactyly-arthropathy-coxa vara-pericarditis syndrome" OR "camptodactyly-arthropathy-pericarditis syndrome" OR "PRG4"

Recall-expansion terms: PRG4

Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: CACP

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • "Jacobs syndrome" also appears on ORPHA:8

Ingested 2026-07-26T21:26:14.567Z